Vividion Therapeutics, Inc. — Form D
Vividion Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-02. The offering totals $135.0M, of which $135.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-03-02
- Form: D
- Accession: 0001841613-21-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $135.0M
- Amount sold: $135.0M
- Investors: 27
- Date of first sale: 2021-02-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-390895
Issuer
- Name: Vividion Therapeutics, Inc.
- CIK: 0001671687
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 5820 NANCY RIDGE DR., SAN DIEGO, CA, 92121
- Phone: (858) 345-4690
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Kristina L Burow | Director | New York, NY |
| John L Clarke | Director | St. Louis, MO |
| Benjamin L Cravatt | Director | San Diego, CA |
| Thomas E Daniel | Director | San Diego, CA |
| Jeffrey Hatfield | Director | San Diego, CA |
| Richard L Heyman | Director | San Diego, CA |
| Jakob E Loven | Director | San Diego, CA |
| Thomas E Woiwode | Director | San Diego, CA |
| Patricia L Allen | Executive Officer | San Diego, CA |
| Jeffrey Hatfield | Executive Officer | San Diego, CA |
| Kristina K Burow | Director | San Diego, CA |
| John K Clarke | Director | Walla Walla, WA |
| John K Clarke | Executive Officer | Walla Walla, WA |
| Diego K Miralles | Director | San Diego, CA |
| Diego K Miralles | Executive Officer | San Diego, CA |
| Fred K Aslan | Executive Officer | San Diego, CA |
| Benjamin K Cravatt | Director | San Diego, CA |
| Jakob K Loven | Director | San Diego, CA |
| Richard K Heyman | Director | San Diego, CA |
| Tom K Daniel | Director | San Diego, CA |
| Thomas K Woiwode | Director | San Diego, CA |
| John K Park | Director | Palo Alto, CA |
| John K Park | Executive Officer | Palo Alto, CA |
Other filings by this issuer (3)
More